RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future.
作者信息
Wen Patrick Y, van den Bent Martin, Vogelbaum Michael A, Chang Susan M
机构信息
Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Department Neuro-Oncology, ErasmusMC Cancer Institute, Rotterdam, Netherlands.
出版信息
Neuro Oncol. 2024 Jan 5;26(1):2-4. doi: 10.1093/neuonc/noad189.
Abstract
摘要
相似文献
1
RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future.RANO 2.0：为未来设计的成人高低级别胶质肿瘤的修订版神经肿瘤学疗效评估（RANO）标准。
Neuro Oncol. 2024 Jan 5;26(1):2-4. doi: 10.1093/neuonc/noad189.
2
Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria.高级别胶质瘤的更新反应评估标准：超越麦克唐纳标准。
Chin Clin Oncol. 2017 Aug;6(4):37. doi: 10.21037/cco.2017.06.26.
3
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. RANO 2.0：成人高级别和低级别胶质瘤反应评估标准更新。
J Clin Oncol. 2023 Nov 20;41(33):5187-5199. doi: 10.1200/JCO.23.01059. Epub 2023 Sep 29.
4
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.新诊断和复发性胶质母细胞瘤中的标准反应评估、神经肿瘤学改良反应评估和神经肿瘤学免疫治疗反应评估的评价。
J Clin Oncol. 2023 Jun 10;41(17):3160-3171. doi: 10.1200/JCO.22.01579. Epub 2023 Apr 7.
5
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.神经肿瘤学中更新的胶质瘤反应评估（ RANO ）
Curr Neurol Neurosci Rep. 2024 Feb;24(2):17-25. doi: 10.1007/s11910-023-01329-4. Epub 2024 Jan 3.
6
Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.神经肿瘤学标准中的疗效评估与临床终点
Magn Reson Imaging Clin N Am. 2016 Nov;24(4):705-718. doi: 10.1016/j.mric.2016.06.003. Epub 2016 Sep 14.
7
Assessment of Brain Tumor Response: RANO and Its Offspring.脑肿瘤反应评估：RANO及其衍生标准
Curr Treat Options Oncol. 2016 Jul;17(7):35. doi: 10.1007/s11864-016-0413-5.
8
Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.儿童神经肿瘤学中的疗效评估：在新诊断的高级别胶质瘤儿科患者的随机II期试验中实施和扩展RANO标准
AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. doi: 10.3174/ajnr.A4782. Epub 2016 Apr 28.
9
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.新型反应/进展测量指标在神经胶质瘤手术治疗中的应用：神经肿瘤学反应评估（RANO）工作组。
Neurosurgery. 2012 Jan;70(1):234-43; discussion 243-4. doi: 10.1227/NEU.0b013e318223f5a7.
10
Response assessment in neuro-oncology.神经肿瘤学中的反应评估。
Curr Oncol Rep. 2011 Feb;13(1):50-6. doi: 10.1007/s11912-010-0143-y.
引用本文的文献
1
Multidisciplinary, Clinical Assessment of Accelerated Deep-Learning MRI Protocols at 1.5 T and 3 T After Intracranial Tumor Surgery and Their Influence on Residual Tumor Perception.颅内肿瘤手术后1.5T和3T加速深度学习MRI协议的多学科临床评估及其对残余肿瘤感知的影响。
Diagnostics (Basel). 2025 Aug 7;15(15):1982. doi: 10.3390/diagnostics15151982.
2
Trends in Efficacy Endpoints in Phase II Glioblastoma Trials: A Regulatory Science Analysis (FY2020-FY2022).胶质母细胞瘤II期试验中疗效终点的趋势：一项监管科学分析（2020财年-2022财年）
Cancers (Basel). 2025 Mar 1;17(5):855. doi: 10.3390/cancers17050855.
3
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma.ATLAS/NOA - 29研究方案：一项关于新诊断的颞叶胶质母细胞瘤患者行前颞叶切除术与全切除术对比的III期随机对照试验。
BMC Cancer. 2025 Feb 20;25(1):306. doi: 10.1186/s12885-025-13682-3.
4
Clinical application of machine-based deep learning in patients with radiologically presumed adult-type diffuse glioma grades 2 or 3.基于机器的深度学习在放射学诊断为2级或3级成人型弥漫性胶质瘤患者中的临床应用
Neurooncol Adv. 2024 Nov 10;6(1):vdae192. doi: 10.1093/noajnl/vdae192. eCollection 2024 Jan-Dec.
5
F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study.F-FET PET/CT有助于诊断MRI检查结果不明确的脑肿瘤患者：一项前瞻性研究。
Ann Nucl Med. 2025 Apr;39(4):342-352. doi: 10.1007/s12149-024-02005-4. Epub 2024 Nov 26.
6
"Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging.使用动态自旋和梯度回波平面回波成像技术对脑肿瘤进行具有可调采集参数的“合成”DSC灌注MRI
AJNR Am J Neuroradiol. 2025 Feb 3;46(2):311-320. doi: 10.3174/ajnr.A8475.
7
Determining Progressive Disease Using RANO 2.0-Further Clarifications and Explanations.使用RANO 2.0确定疾病进展——进一步的说明与解释
Korean J Radiol. 2024 Sep;25(9):859-864. doi: 10.3348/kjr.2024.0476. Epub 2024 Jul 15.
8
Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis.手术切除对比活检对老年胶质母细胞瘤患者的预后价值：一项荟萃分析。
J Neurooncol. 2024 Sep;169(3):469-487. doi: 10.1007/s11060-024-04752-w. Epub 2024 Jul 11.
9
Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas.测量可测量的指标：PET RANO 1.0标准用于弥漫性胶质瘤氨基酸PET的解读
Neuro Oncol. 2024 Mar 4;26(3):401-402. doi: 10.1093/neuonc/noad228.
本文引用的文献
1
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. RANO 2.0：成人高级别和低级别胶质瘤反应评估标准更新。
J Clin Oncol. 2023 Nov 20;41(33):5187-5199. doi: 10.1200/JCO.23.01059. Epub 2023 Sep 29.
2
Amino Acid PET in Neurooncology.神经肿瘤学中的氨基酸正电子发射断层扫描
J Nucl Med. 2023 May;64(5):693-700. doi: 10.2967/jnumed.122.264859. Epub 2023 Apr 13.
3
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.新诊断和复发性胶质母细胞瘤中的标准反应评估、神经肿瘤学改良反应评估和神经肿瘤学免疫治疗反应评估的评价。
J Clin Oncol. 2023 Jun 10;41(17):3160-3171. doi: 10.1200/JCO.22.01579. Epub 2023 Apr 7.
4
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement.自动评估脑胶质瘤负担：一种用于全自动容积和二维测量的深度学习算法。
Neuro Oncol. 2019 Nov 4;21(11):1412-1422. doi: 10.1093/neuonc/noz106.
5
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.基于人工神经网络的 MRI 神经肿瘤学中肿瘤自动定量反应评估：多中心回顾性研究。
Lancet Oncol. 2019 May;20(5):728-740. doi: 10.1016/S1470-2045(19)30098-1. Epub 2019 Apr 2.
6
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.神经肿瘤学中的神经功能评估（NANO）量表：一种用于评估神经功能以纳入神经肿瘤学疗效评估（RANO）标准的工具。
Neuro Oncol. 2017 May 1;19(5):625-635. doi: 10.1093/neuonc/nox029.
7
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.胶质母细胞瘤临床试验中影像学反应评估的修订标准
Neurotherapeutics. 2017 Apr;14(2):307-320. doi: 10.1007/s13311-016-0507-6.
8
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.神经肿瘤学中的免疫治疗反应评估：RANO工作组报告
Lancet Oncol. 2015 Nov;16(15):e534-e542. doi: 10.1016/S1470-2045(15)00088-1.
9
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.神经肿瘤学中的反应评估（ RANO 小组的报告）：弥漫性低级别胶质瘤试验的结果评估。
Lancet Oncol. 2011 Jun;12(6):583-93. doi: 10.1016/S1470-2045(11)70057-2. Epub 2011 Apr 5.
10
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.高级别胶质瘤更新后的反应评估标准：神经肿瘤学工作组的反应评估。
J Clin Oncol. 2010 Apr 10;28(11):1963-72. doi: 10.1200/JCO.2009.26.3541. Epub 2010 Mar 15.
Zotero 插件